Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.24 USD | +5.98% | -3.88% | -61.73% |
Apr. 22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
Apr. 22 | Sector Update: Health Care | MT |
Business Summary
Number of employees: 22
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Cavan
CEO | Chief Executive Officer | 65 | 15-12-31 |
Daren Ure
CTO | Chief Tech/Sci/R&D Officer | - | 19-10-02 |
Stephen Kilmer
IRC | Investor Relations Contact | - | - |
Daniel Trepanier
PRN | Corporate Officer/Principal | - | 19-10-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
CHM | Chairman | 76 | 13-05-14 |
Timothy Block
BRD | Director/Board Member | 69 | 13-11-25 |
Kaouthar Lbiati
BRD | Director/Board Member | 45 | 22-06-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,688 | 0 | 0 | 99.69 % |
Stock B | 1 | 5,472,451 | 5,455,670 ( 99.69 %) | 0 | |
Stock C | 0 | 85,581 | 0 | 0 |
Company contact information
Hepion Pharmaceuticals, Inc.
399 Thornall Street 1st Floor
08837, Edison
+732 902 4000
http://www.hepionpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.73% | 6.4M | |
+9.63% | 115B | |
+13.16% | 107B | |
-13.40% | 22.31B | |
-3.46% | 21.6B | |
-5.29% | 18.23B | |
-38.57% | 17.62B | |
+8.18% | 14.26B | |
+34.60% | 12.37B | |
-26.51% | 8.28B |
- Stock Market
- Equities
- HEPA Stock
- Company Hepion Pharmaceuticals, Inc.